South Africa is facing the possibility of state Aids patients developing "major resistance" to currently prescribed antiretroviral (ARV) drugs, health department director-general Thami Mseleku said on Thursday.
Challenges still to be overcome
"We have a number of challenges - for the number of people who started treatment a long time ago, they are now faced with a situation where they are likely to be developing resistance anyway, and would have to move to the second level of drugs. That in itself is a problem of resistance.
Preparing for the future
Asked if the department was currently trying to source second-line ARVs ahead of any possible resistance phase, Mseleku said: "In preparation we are in discussion with a variety of companies that may actually be able to provide these."
How common is HIV/AIDS? (Statistics)
R2 million to HIV/Aids research